Goettingen, Germany

Martin Leuthold

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Goettingen, DE (2017 - 2024)
  • Göttingen, DE (2019 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Martin Leuthold: Innovator in Biopharmaceutical Processing

Introduction

Martin Leuthold is a prominent inventor based in Goettingen, Germany. He has made significant contributions to the field of biopharmaceutical processes, holding a total of 13 patents. His innovative work focuses on modular processing systems and bioreactor technologies.

Latest Patents

Among his latest patents is a modular processing system and method for the modular construction of a processing system. This system is designed for biopharmaceutical processes and includes at least one first and one second processing unit that can be fluidically connected. Additionally, it features an adapter plate that deflects and controls the fluid flow between the processing units. Another notable patent is for a bioreactor with a filter unit and a method for treating a cell broth. This bioreactor is equipped with a supply channel, filter mediums, and permeate channels, all arranged to optimize the treatment of cell broth.

Career Highlights

Martin Leuthold has worked with notable companies in the biopharmaceutical sector, including Sartorius Stedim Biotech GmbH and The Automation Partnership (Cambridge) Limited. His experience in these organizations has contributed to his expertise in developing innovative processing systems.

Collaborations

Throughout his career, Martin has collaborated with esteemed colleagues such as Stefan Weisshaar and Ulrich Grummert. These partnerships have further enhanced his contributions to the field.

Conclusion

Martin Leuthold is a key figure in the innovation of biopharmaceutical processing technologies. His patents and career achievements reflect his dedication to advancing this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…